Role of Ablative Radiotherapy in the Management of Metastatic Disease: A Patient Data Registry

Role of Ablative Radiotherapy in the Management of Metastatic Disease: A Patient Data Registry

The purpose of this study is to provide a registry of participants in order to assess the acute adverse event rates following ablative radiotherapy for metastatic disease.

Inclusion Criteria:

• Age ≥ 18 years of age
• Radiographic evidence of metastatic disease (may include oligoprogression, oligorecurrence or oligometastasis) at the time of study enrollment
• Planned to receive, currently receiving, or have completed hypofractionated image guided radiotherapy (ablative radiotherapy) to an extracranial site(s)
• Patient must sign study-specific informed consent

Exclusion Criteria:

• None